Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2745 | 2082 | 45.4 | 81% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FENRETINIDE | Author keyword | 136 | 71% | 5% | 111 |
2 | 4 HPR | Author keyword | 67 | 72% | 2% | 52 |
3 | N 4 HYDROXYPHENYL RETINAMIDE | Author keyword | 51 | 83% | 1% | 29 |
4 | RETINOIDS | Author keyword | 38 | 15% | 12% | 240 |
5 | CD437 | Author keyword | 38 | 76% | 1% | 26 |
6 | TAC 101 | Author keyword | 35 | 89% | 1% | 16 |
7 | 4HPR | Author keyword | 27 | 78% | 1% | 18 |
8 | ATYPICAL RETINOIDS | Author keyword | 20 | 100% | 0% | 9 |
9 | ACYCLIC RETINOID | Author keyword | 19 | 71% | 1% | 15 |
10 | CHEMOPREVENT UNIT | Address | 15 | 59% | 1% | 17 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FENRETINIDE | 136 | 71% | 5% | 111 | Search FENRETINIDE | Search FENRETINIDE |
2 | 4 HPR | 67 | 72% | 2% | 52 | Search 4+HPR | Search 4+HPR |
3 | N 4 HYDROXYPHENYL RETINAMIDE | 51 | 83% | 1% | 29 | Search N+4+HYDROXYPHENYL+RETINAMIDE | Search N+4+HYDROXYPHENYL+RETINAMIDE |
4 | RETINOIDS | 38 | 15% | 12% | 240 | Search RETINOIDS | Search RETINOIDS |
5 | CD437 | 38 | 76% | 1% | 26 | Search CD437 | Search CD437 |
6 | TAC 101 | 35 | 89% | 1% | 16 | Search TAC+101 | Search TAC+101 |
7 | 4HPR | 27 | 78% | 1% | 18 | Search 4HPR | Search 4HPR |
8 | ATYPICAL RETINOIDS | 20 | 100% | 0% | 9 | Search ATYPICAL+RETINOIDS | Search ATYPICAL+RETINOIDS |
9 | ACYCLIC RETINOID | 19 | 71% | 1% | 15 | Search ACYCLIC+RETINOID | Search ACYCLIC+RETINOID |
10 | RETINOID | 12 | 13% | 4% | 84 | Search RETINOID | Search RETINOID |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | N 4 HYDROXYPHENYL RETINAMIDE | 165 | 68% | 7% | 146 |
2 | SYNTHETIC RETINOID FENRETINIDE | 97 | 85% | 2% | 51 |
3 | FENRETINIDE | 79 | 57% | 4% | 93 |
4 | 2ND PRIMARY TUMORS | 52 | 30% | 7% | 148 |
5 | 13 CIS RETINOIC ACID | 48 | 19% | 11% | 229 |
6 | ACID RECEPTOR BETA | 42 | 38% | 4% | 88 |
7 | 4 HPR | 32 | 85% | 1% | 17 |
8 | SELECTIVE RETINOIDS | 31 | 54% | 2% | 40 |
9 | RETINAMIDE | 31 | 82% | 1% | 18 |
10 | CARBOXYLIC ACID CD437 | 29 | 88% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Retinoids, Retinoic Acid Receptors, and Cancer | 2011 | 128 | 134 | 31% |
Retinoids and breast cancer: From basic studies to the clinic and back again | 2014 | 13 | 118 | 40% |
Retinoids and their receptors in cancer development and chemoprevention | 2002 | 203 | 105 | 51% |
The promise of retinoids to fight against cancer | 2001 | 491 | 124 | 25% |
Mechanisms of fenretinide-induced apoptosis | 2006 | 100 | 204 | 49% |
Tumor-suppressive activity of retinoic acid receptor-beta in cancer | 2007 | 46 | 103 | 68% |
Retinoid pathway and cancer therapeutics | 2010 | 65 | 188 | 38% |
Retinoic acid receptors and cancers | 2004 | 159 | 107 | 43% |
Strategy and mechanism for the prevention of hepatocellular carcinoma: Phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention | 2009 | 28 | 51 | 59% |
Retinoids in cancer therapy and chemoprevention: promise meets resistance | 2003 | 179 | 132 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEMOPREVENT UNIT | 15 | 59% | 0.8% | 17 |
2 | CLIN CANC PREVENT | 10 | 15% | 2.8% | 59 |
3 | RETINOID PROGRAM | 7 | 50% | 0.5% | 10 |
4 | SECT IMMUNOBIOL DRUG CARRIERS | 4 | 36% | 0.4% | 8 |
5 | CENT TUMOR BIOL | 3 | 100% | 0.1% | 3 |
6 | CATULLO DANIELA BORGOMAINERIO | 3 | 33% | 0.3% | 7 |
7 | OPERAT UNIT PEDIAT | 3 | 60% | 0.1% | 3 |
8 | CHEBIGEN INC | 3 | 42% | 0.2% | 5 |
9 | UNIT 1360 | 3 | 30% | 0.3% | 7 |
10 | MOL CELLULAR PATHOL UNIT | 2 | 36% | 0.2% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000239380 | 9 CIS UAB30//NSC23925//TARGRETIN |
2 | 0.0000206888 | RETINOYLATION//RETINOBENZOIC ACID//RXR |
3 | 0.0000151954 | HETEROAROTINOIDS//ANTIHYPERKERATINIZATION//ANTIHYPERPROLIFERATION |
4 | 0.0000150685 | DIFFERENTIAT CONTROL SECTBLDG 37//ROOM 3A17//BLDG 37 ROOM 2B26 |
5 | 0.0000100562 | CYP26A1//CYP26//RETINOIC ACID |
6 | 0.0000095077 | B TIST ST VINCENTS HLTH SYST//LD CT SCREENING//UNIV HOSP NA BULOVCE |
7 | 0.0000093145 | ANGIOTENSIN CONVERTING ENZYME 1//ANTI THY11//KNOWLEDGE TRANSFER TRANSLATION |
8 | 0.0000087590 | ESTUDOS EST SE OXIDAT 32//MITOCHONDRIAL ELECTRON TRANSFER CHAIN//ESTUDOS EST SE OXIDATIVO |
9 | 0.0000083565 | RETINOYL BETA GLUCURONIDE//RETINOYL GLUCURONIDE//ISOTRETINOIN |
10 | 0.0000074892 | RARRES3//TIG3//H REV107 |